New opportunities for innovative SMEs
The European Union (EU) has realized that too few newly developed products are making it onto the market in Europe. For this reason, it is utilizing the...
More details More detailsShaping the future of modern drug discovery
Video interview with Professor Dr. Gebhard Schertler Pharmaceutical and biotechnological industries often depend on the information acquired through...
More detailsWomen’s passion – the new frontier of innovation
Based on the “Appassionate” project – a book about women who transform their own passion into enterprises My work has always been to find stories...
More detailsEmerging applications of modular nanomaterials
When, back in 1999, the journal Nature published a letter about a material with a surface area of 2900 square meters in a single gram, many people believed...
More detailsLife Science basic research on the top level
The Paul Scherrer Institute (PSI) is Switzerland’s biggest research institute for natural and engineering sciences. It hosts most of the country’s...
More detailsA perfect site for biotech and pharma companies!
Drug discovery has come a long way from crude extracts to pure chemicals, from guess work to a structural and targeted approach to finding new and better...
More detailsInfrastructure and R&D solutions for biotech and pharmaceutical industries
The Swiss Light Source (SLS) at the Paul Scherrer Institute (PSI) and the free-electron laser (SwissFEL) provide beams of exceptional brightness and stability...
More detailsBiotech and pharma at PARK INNOVAARE
PARK INNOVAARE provides the best possible operating conditions for biotech and pharmaceutical companies. This includes the availability of modern laboratories...
More detailsCorporate Innovation Makeover: Excubation rules for the core business
This blog post is dedicated to the final three Excubation rules, and thus concludes our Corporate Innovation Makeover series. These three rules focus on...
More detailsCorporate Innovation Makeover: Excubation rules 3 and 4
Building on the excubation conversation we started in this blog series, and having introduced first two rules of the approach, we dive here into the next...
More detailsUnprecedented speed and success rate with delivering ligand-bound GPCR structures
Modern drug discovery greatly benefits from knowledge of how a drug interacts with its molecular drug target. Membrane protein drug targets represent a...
More detailsHow can KPI steer your innovation process?
PARK INNOVAARE works at the interface of technology-driven companies and public research, such as at the nearby Paul Scherrer Institute (PSI). In one of...
More details